Related Experiment Video
Updated: Aug 30, 2025

09:50
Deep and Spatially Controlled Volume Ablations using a Two-Photon Microscope in the Zebrafish Gastrula
Published on: July 15, 2021
2.0K
Moses and Moses 2.0 for Laser Lithotripsy: Expectations vs. Reality
Mariela Corrales1,2, Alba Sierra1,2, Olivier Traxer1,2
1GRC Urolithiasis No. 20 Tenon Hospital, Sorbonne University, F-75020 Paris, France.
Journal of Clinical Medicine
|August 26, 2022
Summary
Moses technology (MT) in laser lithotripsy offers shorter lasing times but lower efficacy. Current evidence does not support its superiority over other laser lithotripsy methods for stone removal.
Area of Science:
- Urology
- Medical Engineering
- Laser Technology
Background:
- Moses technology aims to control the Moses effect in Ho:YAG laser lithotripsy by dividing energy pulses.
- This pulse modulation technique delivers most energy in the second sub-pulse, aiming for improved stone fragmentation.
Purpose of the Study:
- To evaluate the efficacy and clinical benefits of Moses technology (MT) in Ho:YAG laser lithotripsy compared to conventional laser modes.
- To review existing literature on Moses 1.0 and 2.0 for endocorporeal laser lithotripsy.
Main Methods:
- A literature review was conducted, selecting clinical trials and laboratory studies of Moses 1.0 and 2.0 up to June 2022.
- Included studies compared Moses technology (MT) with standard low pulse (LP) and high pulse (HP) Ho:YAG lasers.
Main Results:
- Moses technology (MT 1.0) demonstrated shorter lasing times but reduced laser efficacy (higher J/mm³).
- No significant differences in lasing time, operative time, or stone-free rates were found when comparing MT 1.0 to regular mode HP Ho:YAG lasers.
- Moses 2.0 studies are limited; higher frequencies consumed more energy (J/mm³) for similar stone-free rates compared to MT 1.0.
Conclusions:
- Current evidence does not support the use of high-pulse Ho:YAG lasers with Moses technology over low-pulse Ho:YAG or TFL lasers.
- Further high-quality clinical trials are needed to validate the benefits of Moses 2.0 technology.

